May 09,2022

Effectiveness of Telemedicine in Managing Diabetes in Pregnancy: A Systematic Review and Meta-Analysis

This study assesses the effects of telemedicine solutions for managing gestational and pregestational diabetes.

CLINICAL STUDY

#telehealth

View Analyst & Ambassador Comments
Go to original news
May 10,2022

Indigo Appoints Emmet Lydon as Chief Operating Officer

Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, today announces the appointment of Emmet Lydon as Chief Operating Officer.

View Analyst & Ambassador Comments
Go to original news
May 10,2022

Dexcom Announces Upcoming Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences: BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 5:40pm (EST), and William Blair 42nd Annual Growth Stock Conference on Wednesday, June 8, 2022 at 5:00pm (EST).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 10,2022

Vida Health Announces Medical Prescribing Services for Physical and Mental Health

Vida Health announced its expansion into new medical prescribing services for treating physical and mental health conditions together, solidifying its position as a leader in comprehensive cardiometabolic virtual care.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
May 10,2022

Senseonics Holdings, Inc. Reports First Quarter 2022 Financial Results

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended March 31, 2022.

View Analyst & Ambassador Comments
Go to original news
May 10,2022

Outlook on the Blood Glucose Device Global Market to 2027 - Featuring Roche Diagnostic, Abbott Laboratories and Medtronic Among Others

The global Self-Monitoring Blood Glucose Devices Market is expected to reach US$ 46.69 Billion in 2027.

#bgm

View Analyst & Ambassador Comments
Go to original news
May 10,2022

Type 2 Diabetes Reversal Leader Virta Health Appoints Shane Henderson as Chief Technology Officer

Virta Health announced the addition of Shane Henderson as Chief Technology Officer (CTO).

View Analyst & Ambassador Comments
Go to original news
May 12,2022

First Outpatient Clinical Trial of a Full Closed-Loop Artificial Pancreas System in South America

The first outpatient trial of the automatic regulation of glucose (ARG) algorithm using an own artificial pancreas (AP) platform and doubling the duration of previous phases is presented.

CLINICAL STUDY

#closed loop

View Analyst & Ambassador Comments
Go to original news
May 12,2022

Hygieia Launches d-Nav® Clinical Partnership Program at AACE Annual Meeting

The d-Nav Clinical Partnership Program is turnkey. It provides patients with access to d-Nav autonomous insulin dose technology and a clinical support team.

PRODUCT

#dtx

View Analyst & Ambassador Comments
Go to original news
May 12,2022

DarioHealth Reports Record Quarterly Revenues in its 2022 First Quarter

Total Q1 revenue of $8.06 million increased 124% over the comparable prior year period and 34% sequentially over Q4 2021.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES